NewsPR Newswire
Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference
· Published
Article summary
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that John Friend, MD,...
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…